United States News Todas as matérias

Crypto investors face a far more complex 2026 tax filing season as Form 1099-DA reporting and wallet by wallet accounting reshape how digital assets are reported.

The United States has extended duty free access for selected Israeli agricultural products through 2026 while correcting technical issues in its tariff schedule.

Spot XRP ETFs in the United States extended a 29-day inflow streak in December, bucking heavy outflows from Bitcoin and Ether funds amid volatile markets.

BitMine accelerated its Ethereum accumulation as year-end tax-loss selling and thin holiday trading capped price gains, according to Fundstrat’s Tom Lee.

Pump.fun’s revival of livestreaming in 2025 has reshaped creator monetisation by blending viral content with tokenised ownership, while reigniting debate over risk, sustainability, and sensationalism.

A US crypto policy shift has driven African nations to overhaul regulation, accelerating adoption and reshaping digital asset markets across the continent.

Crypto has lagged gold and stocks since November, but analysts say shifting liquidity and whale behaviour could give digital assets a chance to catch up in 2026.

Grayscale has filed with US regulators to list an exchange-traded product tied to Bittensor’s TAO token on NYSE Arca.

Deep divisions within the Federal Reserve over 2026 rate cuts are creating uncertainty for Bitcoin and broader crypto market momentum.

Binance has temporarily halted Visa and Mastercard withdrawals for Ukrainian users following regulatory changes affecting its payment provider.

Grayscale says rising demand for alternative stores of value and clearer US regulation could set the stage for the next crypto bull market in 2026.

Analysts say further Federal Reserve rate cuts in 2026 could reignite retail and institutional interest in crypto despite current weak market sentiment.

Crypto is beginning to move beyond crime-focused portrayals as Netflix develops a rare mainstream film centred on digital assets.

US prosecutors are urging a federal judge to reject a DeFi Education Fund brief as the court considers a possible retrial in an Ethereum exploit case.

FINRA has fined American Portfolios and ordered millions in restitution after finding undisclosed interest retention and misleading fee disclosures in its cash sweep programme.

Abu Dhabi is drawing global crypto firms with clear regulation, tax incentives, and strong institutional backing through its ADGM licensing framework.

QED Investors expects AI-driven credit models, execution-focused growth, and valuation discipline to shape the global fintech sector in 2026.

Nvidia (NASDAQ:NVDA) is reportedly in advanced discussions to acquire AI21 Labs, an Israel-based artificial intelligence startup, in a deal potentially valued at up to $3 billion, according to a report from Calcalist.

FTAI Aviation (NASDAQ:FTAI) saw its shares rise by 8.8% in the morning session after announcing the launch of FTAI Power, a new venture aimed at repurposing its CFM56 aircraft engines into 25-megawatt power turbines.

Nukkleus (NASDAQ:NUKK) has successfully closed its acquisition of Tiltan Software Engineering, making the Israeli defense technology firm a wholly owned subsidiary.

Lexaria Bioscience Corp. (NASDAQ:LEXX) announced positive findings from its Phase 1b clinical study GLP-1-H24-4, a 12-week chronic trial focusing on its DehydraTECH™ (DHT) delivery platform in comparison to the Rybelsus® control arm.

Binance has confirmed the suspension of Visa and Mastercard withdrawals for users in Ukraine following changes linked to its fiat payment provider.

Cycurion closed 2025 with a strong financial position, reporting an $80 million contracted backlog and bolstered liquidity as the company accelerates into 2026.

For the third quarter of 2025, Cycurion, which trades on the Nasdaq under the ticker CYCU, reported revenue of $3.83 million, a 13.9% year-over-year decrease. However, total assets grew to $32.31 million, an increase of 26.4%, and cash reserves rose significantly to $3.65 million, compared to just $0.04 million at the end of 2024.

The company saw net financing inflows of $10.78 million and is forecasting a Q1 2026 run-rate revenue of approximately $4.17 million, which would annualize to around $16.66 million.

Recent business wins include a multi-year telecom deployment with potential revenue exceeding $1 million, a state and local government data modernization project, and a $1.1 million county contract. Cycurion also declared a pro-rata share dividend of $0.0080 per share, payable around December 30, 2025.

Cycurion’s strategic focus on government and commercial sectors continues to drive growth as the company strengthens its foundation for expansion into 2026.

Denali Therapeutics (NASDAQ:DNLI) announced promising Phase 1/2 results for tividenofusp alfa (DNL310) in the treatment of Hunter syndrome, with the data published in The New England Journal of Medicine supporting an FDA Priority Review. The FDA has set a Prescription Drug User Fee Act (PDUFA) date for April 5, 2026.